• No results found

[PDF] Top 20 Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1 1)

Has 10000 "Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1 1)" found on our website. Below are the top 20 most common "Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1 1)".

Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1 1)

Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1 1)

... one assay originally de- veloped and already approved for use for the measurement of the viral load in HIV-1 carriers may be equally valid for the quantification of HIV-2 viremia is of ...the ... See full document

5

Correlation between Human Immunodeficiency Virus Type 1 (HIV 1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV 1 and Abbott RealTime HIV Load Tests

Correlation between Human Immunodeficiency Virus Type 1 (HIV 1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV 1 and Abbott RealTime HIV Load Tests

... The plasma human immunodeficiency virus (HIV) RNA load is used in the clinical routine for the moni- toring of HIV infection and the patient’s response to antiretroviral ...HIV ... See full document

6

Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B Infections

Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B Infections

... the RNA of HIV-2 subtype A and subtype B strains in ...The detection limit is 250 copy equivalents/ml, and the reproducibility of the assay is ...the assay, as ... See full document

6

Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV 1) RNA bDNA v3 0, Cobas AmpliPrep/Cobas TaqMan HIV 1, and NucliSens HIV 1 EasyQ v1 2, Testing HIV 1 Non B Subtypes and Recombinant Variants

Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV 1) RNA bDNA v3 0, Cobas AmpliPrep/Cobas TaqMan HIV 1, and NucliSens HIV 1 EasyQ v1 2, Testing HIV 1 Non B Subtypes and Recombinant Variants

... of human immunodeficiency virus type 1 (HIV-1) RNA levels is important for understand- ing the natural history of HIV infection, predicting disease progression to AIDS, ... See full document

6

Multicenter Evaluation of the Performance Characteristics of the NucliSens HIV 1 QT Assay Used for Quantitation of Human Immunodeficiency Virus Type 1 RNA

Multicenter Evaluation of the Performance Characteristics of the NucliSens HIV 1 QT Assay Used for Quantitation of Human Immunodeficiency Virus Type 1 RNA

... more RNA target per amplification ...the plasma input volume from 1 to 2 ml increased the sensitivity of the assay to 50 HIV-1 RNA copies/ml, with a detection rate ... See full document

10

Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA

Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA

... of plasma HIV-1 RNA levels appears to hold many advantages over other virologic tests for HIV-1 infection ...antigen, plasma HIV-1 RNA levels are measurable in the vast ... See full document

5

Performance Characteristics of the QUANTIPLEX HIV 1 RNA 3 0 Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

Performance Characteristics of the QUANTIPLEX HIV 1 RNA 3 0 Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

... HIV-1 RNA in ...and detection methods, including reverse tran- scription (RT) followed by PCR and colorimetric detection (RT-PCR assay; Roche Molecular Systems, ...orimetric ... See full document

9

Ultrasensitive Reverse Transcription PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

Ultrasensitive Reverse Transcription PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

... of 2 min at 50°C; 30 min at 60°C (for RT); 4 PCR cycles of 10 s at 95°C, 10 s at 55°C, and 10 s at 72°C; 26 PCR cycles of 10 s at 90°C, 10 s at 60°C, and 10 s at 72°C; and 15 min at ...H 2 O 2 and ... See full document

6

Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV 1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep Cobas Amplicor, Roche Cobas AmpliPrep Cobas TaqMan HIV 1, and BioMerieux NucliSENS Easy

Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV 1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep Cobas Amplicor, Roche Cobas AmpliPrep Cobas TaqMan HIV 1, and BioMerieux NucliSENS EasyQ HIV 1 Assays

... current NucliSENS HIV-1 technology, RealTime HIV-1 re- quires less manual preparation (38) and therefore fewer ...This assay showed overall good perfor- mance and potential for use with ... See full document

9

Multicenter Comparison of Roche COBAS AMPLICOR MONITOR Version 1 5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex Version 3 0 for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma

Multicenter Comparison of Roche COBAS AMPLICOR MONITOR Version 1 5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex Version 3 0 for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma

... an assay can be influenced by characteristics such as specimen throughput and volume requirements, ease of execution, in- strument work space, and costs (Table ...and NucliSens are equivalent to that of ... See full document

12

Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target

Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target

... (e.g., NucliSens HIV-1 QT assay [Or- ganon Teknika, Boxtel, The Netherlands] or Amplicor version ...direct detection of HIV-1 RNA by hybridization with labeled probes ... See full document

6

Evaluation of the Abbott LCx HIV 1 RNA Quantitative, a New Assay for Quantitative Determination of Human Immunodeficiency Virus Type 1 RNA

Evaluation of the Abbott LCx HIV 1 RNA Quantitative, a New Assay for Quantitative Determination of Human Immunodeficiency Virus Type 1 RNA

... HIV RNA Quantitative ...the assay controls and clinical samples were ex- tracted by centrifugation and separation using a QIAAmp col- umn and subjected to amplification with primers targeted at a ... See full document

5

Flow cytometric immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 1 using insoluble precursor forms of recombinant polyproteins as carriers and antigens

Flow cytometric immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 1 using insoluble precursor forms of recombinant polyproteins as carriers and antigens

... detect human immunodeficiency virus type 1 (HIV-1) infection since the tests were first licensed in 1985 ...the detection of HIV DNA and RNA by PCR and virus ... See full document

8

Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy

Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy

... HIV RNA  1000 copies/mL, the data are insufficient to determine if MTCT rates would be further reduced by elective cesarean ...HIV RNA levels of 1000 copies/mL were reported to have MTCT rates of ... See full document

13

Development, Evaluation, and Validation of an Oligonucleotide Probe Hybridization Assay To Subtype Human Immunodeficiency Virus Type 1 Circulating Recombinant Form CRF02 AG

Development, Evaluation, and Validation of an Oligonucleotide Probe Hybridization Assay To Subtype Human Immunodeficiency Virus Type 1 Circulating Recombinant Form CRF02 AG

... hybridization assay, CRF02_AG predictions for the validation panel of the differ- ent cohorts were as follows: Coˆte d’Ivoire, ...the assay results were compared with the subtype classifications of ... See full document

6

Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA

Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA

... of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) ...screening plasma specimens for the presence of HIV-1 and HCV ... See full document

12

Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay

Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay

... Human immunodeficiency virus type 1 (HIV-1) entry into target cells relies on a complex interaction between viral and cellular proteins, eventually leading to viral and ... See full document

9

Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper

Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper

... dried plasma spots (DPSs) as a source of material for virus quantification, human immunodefi- ciency virus type 1 (HIV-1) RNA levels were quantified in matched DPS ... See full document

7

Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome

Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome

... HIV-1 RNA levels in blood in transmission and disease ...HIV-1 RNA testing ideally be collected in tubes con- taining EDTA, processed within 6 h of collection (but up to 24 h is still ... See full document

9

HIV Load Testing with Small Samples of Whole Blood

HIV Load Testing with Small Samples of Whole Blood

... established plasma VL assay for the use with WB. The assay principle of the CAP/CTM in- cludes a nonspecific capture step based on silica beads and a RT-PCR and therefore does not discriminate ... See full document

7

Show all 10000 documents...